계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Gaugene
company
About
Gaugene provides hematology testing instruments, reagents, and services for IVD users.
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥100M
- Industries
- Biotechnology,Health Diagnostics
- Founded date
- Jan 1, 2017
- Operating Status
- Active
Gaugene provides hematology testing instruments, reagents, and services for IVD users. Gaugene is a high-tech enterprise co-sponsored by core technology management backbones of well-known domestic IVD companies with rich management experience who master the industry’s top technologies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥100M
Gaugene has raised a total of
¥100M
in funding over 2 rounds. Their latest funding was raised on
Jul 15, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 15, 2022 | Series B | ¥100M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Gaugene is funded by 2 investors.
Anbiping
and Huihe Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Anbiping
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
